Integra LifeSciences Reports Fourth Quarter 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Integra LifeSciences (IART) Tops Q4 EPS by 5c
February 24, 2015 6:18 AM ESTIntegra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.94, $0.05 better than the analyst estimate of $0.89. Revenue for the quarter came in at $252.2 million versus the consensus estimate of $244.39 million.
Integra LifeSciences sees FY2015 EPS of $3.05-$3.23, versus the consensus of $3.27. Integra LifeSciences sees FY2015... More
